Publication date: Aug 07, 2024
Emerging infectious diseases (EIDs) can disrupt the healthcare system, causing regulatory changes that affect the healthcare-seeking process and potentially increase patient-physician dissatisfaction. This study aimed to collect and analyze patients’ and physicians’ complaints during an EID outbreak to inform potential clues regarding medical quality and patient safety enhancement in future dealing with EIDs, employing text mining methodologies. In this descriptive study, complaint records from January 2020 to February 2023 at West China Hospital, a national medical facility in China, were analyzed. Patient and physician complaints have been retrospectively retrieved from the record from the medical department, and then categorized into distinct groups based on reporting reasons, encompassing COVID-19-related policies, healthcare access, availability of medical resources, and financial concerns. During the COVID-19 pandemic, 541 COVID-19-related complaints were identified: 330 (61. 00%) from patients and 211 (39. 00%) from physicians. The monthly volume of complaints fluctuated, starting at 10 in 2020, peaking at 21 in 2022, and dropping to 14 in 2023. Most complaints from inpatients were expressed by older males aged 40 to 65 (38. 82%, 210/541). The primary source of complaints was related to mandatory COVID-19 policies (79. 30%, 429/541), followed by concerns regarding timely healthcare services (31. 61%, 171/541). Few complaints were expressed regarding the insufficiency of medical resources (2. 77%, 15/541) and the high costs (4. 25%, 23/541). The frequency of complaints expressed by doctors and patients in the emergency department was higher compared with other departments (24. 58%, 133/541). Increased complaints may serve as a primitive and timely resource for investigating the potential hazards and drawbacks associated with policies pertaining to EIDs. Prompt collection and systematical analysis of patient and physician feedback could help us accurately evaluate the efficacy and repercussions of these policies. Implementing complaints-based assessment might improve care standards in forthcoming healthcare environments grappling with EIDs.
Open Access PDF
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | emerging infectious diseases |
disease | MESH | COVID-19 |
disease | IDO | process |
disease | IDO | quality |
disease | IDO | facility |
disease | VO | monthly |
disease | VO | volume |
drug | DRUGBANK | Dihydrotachysterol |
disease | VO | frequency |
disease | MESH | emergency |
disease | MESH | Infectious Diseases |
drug | DRUGBANK | Guanosine |
drug | DRUGBANK | Coenzyme M |
drug | DRUGBANK | Troleandomycin |
disease | VO | time |
drug | DRUGBANK | Trestolone |
disease | IDO | contact tracing |
disease | MESH | marital status |
drug | DRUGBANK | Nevirapine |
disease | MESH | critically ill |
disease | IDO | blood |
disease | MESH | death |
disease | MESH | infection |
disease | VO | vaccination |
disease | MESH | tumor |
disease | MESH | aortic dissection |
disease | MESH | coronary heart disease |
disease | VO | dead |
disease | VO | effective |
drug | DRUGBANK | Tretamine |
disease | VO | vaccine |
disease | VO | protocol |
disease | MESH | social stigma |
disease | VO | population |
disease | VO | vaccine effectiveness |
drug | DRUGBANK | Methylergometrine |